Breaking News Instant updates and real-time market news.

IMAX

IMAX

$29.08

0.05 (0.17%)

, GOOG

Alphabet

$785.94

10.86 (1.40%)

06:04
10/11/16
10/11
06:04
10/11/16
06:04

IMAX, ODEON, UCI Cinemas to launch first IMAX VR center in Europe

IMAX (IMAX) announced an agreement with leading European exhibitor, ODEON & UCI Cinemas Group, to install the first pilot IMAX VR center in Europe at its Printworks multiplex location in Manchester, England. The center, which the parties are planning to open by the end of 2016, will deliver guests immersive, multi-dimensional VR experiences, including entertainment content and games. IMAX will provide the center an ongoing array of new, premium interactive content experiences that are expected to range between 5 and 15 minutes in length each. The company is in advanced stages with several content developers, including Hollywood studios and gaming publishers, to produce and distribute high-quality VR experiences to its centres. IMAX also plans to eventually incorporate premium content resulting from the cinema-grade virtual reality camera that it is currently developing in partnership with Google (GOOG).

IMAX

IMAX

$29.08

0.05 (0.17%)

GOOG

Alphabet

$785.94

10.86 (1.40%)

  • 11

    Oct

  • 23

    Oct

  • 27

    Oct

  • 10

    Nov

  • 15

    Jan

IMAX IMAX
$29.08

0.05 (0.17%)

07/20/16
ROTH
07/20/16
INITIATION
Target $38
ROTH
Buy
IMAX reinitiated with a Buy at Roth Capital
Roth Capital analyst Darren Aftahi reinitiated coverage of IMAX with a Buy rating and $38 price target, citing the company's growing network of theaters and differentiated technology platform and the increasing global box office.
07/20/16
07/20/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Charter (CHTR) initiated with a Buy at Argus. 2. Panera Bread (PNRA) initiated with an Outperform at RBC Capital. 3. IMAX (IMAX) reinitiated with a Buy at Roth Capital. 4. Harman (HAR) initiated with a Buy at Deutsche Bank. 5. MyoKardia (MYOK) initiated with an Outperform at BMO Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/06/16
ADAM
09/06/16
NO CHANGE
Target $39
ADAM
Buy
IMAX downward revisions could provide a buying opportunity, says Canaccord
Canaccord analyst Aravinda Galappatthige said IMAX's Q3 box office is trending below expectations and lowered its Q3 revenue estimate to $76.6M from $88.7M and earnings to 2c compared to 10c consensus. The analyst views the weak Q3 as an opportunity to buy shares at attractive levels as downward revisions occur and said deals signed in 2016 thus far have secured the longevity of IMAX's growth story for several years. Galappatthige rates IMAX a Buy with a $39 price target on shares.
09/21/16
RILY
09/21/16
DOWNGRADE
Target $42.5
RILY
Neutral
DTS, Inc. downgraded to Neutral from Buy at B. Riley
B. Riley analyst Eric Wold downgraded DTS, Inc. (DTSI) to Neutral citing the takeover by Tessera (TSRA). Following recent deals, the analyst views IMAX (IMAX) as a potential target.
GOOG Alphabet
$785.94

10.86 (1.40%)

09/28/16
MZHO
09/28/16
DOWNGRADE
Target $15
MZHO
Underperform
Mizuho cuts Twitter to Underperform with $15 price target
Mizuho analyst Neil Doshi downgraded Twitter to Underperform from Neutral based on valuation. The shares are up 45% since the company reported Q2 results, primarily driven by potential buyout comments in media reports, Doshi tells investors in a research note. The stock at current levels is overvalued as Twitter's business fundamentals "have deteriorated significantly" over the past 12 months, the analyst contends. Doshi believes many of the M&A scenarios are unlikely to play out. He puts potential acquirers Salesforce (CRM) and Alphabet (GOOG, GOOGL) in the "maybe" camp, but he still has some reservations about these deals happening. The analyst believes investors of both companies would view a buyout of Twitter as negative. Doshi keeps a $15 price target for Twitter shares. The stock closed yesterday up 35c to $23.72. Loop Capital this morning also downgraded Twitter to Sell.
09/28/16
09/28/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Alphabet (GOOG, GOOGL) downgraded to Underperform from Neutral at Wedbush with analyst James Dix citing concerns that the "Four Horsemen of the Search Apocalypse" -- self-identified consumers, consumer control of IP-delivered ads, payments innovation, and attention markets -- might arrive. 2. AT&T (T) downgraded to Neutral from Buy at UBS with analyst John Hodulik citing expectations for lower earnings growth. 3. Macy's (M) downgraded to Neutral from Outperform at Credit Suisse with analyst Michael Exstein saying the retailer, after outlining in August its operations and merchandising strategies, is now in an execution phase. 4. Twitter (TWTR) downgraded to Underperform from Neutral at Mizuho and to Sell from Hold at Loop Capital. 5. Galectin Therapeutics (GALT) downgraded to Sell from Buy at Roth Capital with analyst Sa'ar Yaniv citing the company's announcement that NASH-FX, GR-MD-02's Phase 2a study in NASH fibrosis, failed both primary and secondary endpoints. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/06/16
SBSH
10/06/16
NO CHANGE
Target $89
SBSH
Buy
Citi says Salesforce buying Twitter 'nearly impossible' above $28/share
Citi analyst Walter Pritchard believes a Salesforce (CRM) acquisition of Twitter (TWTR) is possible financially but that such a deal would put "significant constraints" on the company for the next three-plus years. The analyst sees "very little reason" for Salesforce to own Twitter and feels the acquisition "would pose a difficult decision" for CEO Marc Benioff and the board. Salesforce closed yesterday down 6%, or $4.21, to $68.42. Recode reported last night that the company is likely the only bidder left for Twitter after Disney (DIS) and Alphabet (GOOG) opted not to pursue a deal while Apple (AAPL) is unlikely. Twitter in pre-market trading is down 14% to $21.50. In order for Salesforce to avoid a shareholder vote, it would have to borrow $7.5B to fund the transaction if Twitter were valued at $20B, or $27.50-$28 per share, Pritchard tells investors in a research note. This is a level that likely constrains the company with little additional borrowing capacity for other deals, the analyst contends. He thinks the deal is "nearly impossible to do" for Salesforce should the bidding for Twitter go above $20B or $28 per share. Pritchard has a Buy rating on Salesforce with an $89 price target.
10/10/16
WELS
10/10/16
NO CHANGE
WELS
Alphabet, Facebook can meet Street estimates, says Wells Fargo
Wells Fargo says that investors are concerned about the ability of Facebook (FB) and Google (GOOG,GOOGL) to meet Street estimates because forecasts continue to indicate that TV's ad share will be relatively stable over the next two years. But Wells says that Facebook and Google will continue to gain share from "non-TV media" and could see increased revenue from "non-advertising marketing services" such as sponsorships and public relations. Wells keeps Outperform ratings on both stocks.

TODAY'S FREE FLY STORIES

LMT

Lockheed Martin

$332.26

-0.74 (-0.22%)

16:07
01/19/18
01/19
16:07
01/19/18
16:07
Periodicals
Breaking Periodicals news story on Lockheed Martin »

U.S. approves sale of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 07

    Mar

CPLA

Capella Education

$80.50

0.7 (0.88%)

, STRA

Strayer

$93.08

0.9 (0.98%)

16:06
01/19/18
01/19
16:06
01/19/18
16:06
Hot Stocks
Capella Education shareholders approve proposed merger with Strayer »

Capella Education (CPLA)…

CPLA

Capella Education

$80.50

0.7 (0.88%)

STRA

Strayer

$93.08

0.9 (0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 19

    Jan

ADM

Archer Daniels

$40.61

0.13 (0.32%)

, BG

Bunge

$69.78

0.14 (0.20%)

16:03
01/19/18
01/19
16:03
01/19/18
16:03
Periodicals
Archer Daniels made takeover approach to Bunge, WSJ says »

Archer Daniels Midland…

ADM

Archer Daniels

$40.61

0.13 (0.32%)

BG

Bunge

$69.78

0.14 (0.20%)

GLNCY

Glencore

$11.29

-0.02 (-0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

  • 14

    Feb

C

Citi

$78.16

0.77 (0.99%)

16:01
01/19/18
01/19
16:01
01/19/18
16:01
Conference/Events
Citigroup to hold a conference call »

CFO Gerspach and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 24

    Jan

GOLF

Acushnet Holdings

$21.50

0.65 (3.12%)

16:01
01/19/18
01/19
16:01
01/19/18
16:01
Hot Stocks
Acushnet Holdings acquires Linkgs & Kings, terms not disclosed »

Acushnet Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BG

Bunge

$69.79

0.145 (0.21%)

, ADM

Archer Daniels

$40.66

0.18 (0.44%)

15:58
01/19/18
01/19
15:58
01/19/18
15:58
Hot Stocks
Breaking Hot Stocks news story on Bunge, Archer Daniels »

Bunge jumps 10% after…

BG

Bunge

$69.79

0.145 (0.21%)

ADM

Archer Daniels

$40.66

0.18 (0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

  • 14

    Feb

BG

Bunge

$69.76

0.12 (0.17%)

, ADM

Archer Daniels

$40.66

0.18 (0.44%)

15:57
01/19/18
01/19
15:57
01/19/18
15:57
Periodicals
Breaking Periodicals news story on Bunge, Archer Daniels »

Archer Daniels made…

BG

Bunge

$69.76

0.12 (0.17%)

ADM

Archer Daniels

$40.66

0.18 (0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

  • 14

    Feb

HGT

Hugoton Royalty Trust

15:57
01/19/18
01/19
15:57
01/19/18
15:57
Hot Stocks
Breaking Hot Stocks news story on Hugoton Royalty Trust »

Hugoton Royalty Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMCSA

Comcast

$41.85

0.17 (0.41%)

15:50
01/19/18
01/19
15:50
01/19/18
15:50
Options
Bullish option play in Comcast ahead of earnings next week »

Bullish option play in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

SLB

Schlumberger

$76.33

-0.0384 (-0.05%)

15:35
01/19/18
01/19
15:35
01/19/18
15:35
Recommendations
Schlumberger analyst commentary  »

Schlumberger price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

HGT

Hugoton Royalty Trust

15:35
01/19/18
01/19
15:35
01/19/18
15:35
Hot Stocks
Breaking Hot Stocks news story on Hugoton Royalty Trust »

Hugoton Royalty Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVGO

Broadcom

$269.80

3.99 (1.50%)

, QCOM

Qualcomm

$68.05

0.03 (0.04%)

15:31
01/19/18
01/19
15:31
01/19/18
15:31
Periodicals
FTC in place to make second request over Broadcom's Qualcomm bid, Reuters says »

The U.S. Federal Trade…

AVGO

Broadcom

$269.80

3.99 (1.50%)

QCOM

Qualcomm

$68.05

0.03 (0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

A

Agilent

$73.00

0.81 (1.12%)

15:30
01/19/18
01/19
15:30
01/19/18
15:30
Options
Agilent attracts a vote of confidence as shares reach 17-year highs »

Agilent attracts a vote…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FBK

FB Financial

$43.80

0.5 (1.15%)

15:23
01/19/18
01/19
15:23
01/19/18
15:23
Conference/Events
FB Financial management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

ASNA

Ascena Retail

$2.11

-0.01 (-0.47%)

15:20
01/19/18
01/19
15:20
01/19/18
15:20
Options
Ascena Retail attracts upside call buying »

Ascena Retail attracts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:18
01/19/18
01/19
15:18
01/19/18
15:18
Conference/Events
RBC Capital equity strategy analyst holds luncheon meeting »

Equity Strategy Analyst…

$NSD

NASDAQ Market Internals

15:17
01/19/18
01/19
15:17
01/19/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

15:16
01/19/18
01/19
15:16
01/19/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IWM

iShares Trust Russell 2000 Index Fund

$158.42

1.88 (1.20%)

, RUT

Russell 2000 Index

15:14
01/19/18
01/19
15:14
01/19/18
15:14
Technical Analysis
On The Fly: Weekly technical notes for Russell 2000 »

At time of writing the…

IWM

iShares Trust Russell 2000 Index Fund

$158.42

1.88 (1.20%)

RUT

Russell 2000 Index

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKTX

Akari Therapeutics

$3.60

-0.17 (-4.51%)

15:08
01/19/18
01/19
15:08
01/19/18
15:08
Conference/Events
Akari Therapeutics management to meet with William Blair »

Group luncheon to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

XLY

Consumer Discretionary Sector SPDR

$105.56

0.8668 (0.83%)

, XLV

Health Care Select Sector SPDR

$88.26

0.151 (0.17%)

15:05
01/19/18
01/19
15:05
01/19/18
15:05
Technical Analysis
On The Fly: Weekly technical notes for S&P 500 »

The S&P 500 (SPX) is…

XLY

Consumer Discretionary Sector SPDR

$105.56

0.8668 (0.83%)

XLV

Health Care Select Sector SPDR

$88.26

0.151 (0.17%)

XLE

Energy Select Sector SPDR

$76.30

-0.1821 (-0.24%)

XLK

Technology Select Sector SPDR

$67.69

0.015 (0.02%)

XLI

Industrial Select Sector SPDR

$79.64

0.1772 (0.22%)

XLU

Utilities SPDR

$49.99

-0.15 (-0.30%)

XLP

Consumer Staples Sector SPDR

$58.01

0.615 (1.07%)

SPY

SPDR S&P 500 ETF Trust

$280.02

0.875 (0.31%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JOUT

Johnson Outdoors

$62.61

-0.71 (-1.12%)

15:04
01/19/18
01/19
15:04
01/19/18
15:04
Initiation
Johnson Outdoors initiated  »

Johnson Outdoors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

EPC

Edgewell Personal Care

$58.26

-1.725 (-2.88%)

15:00
01/19/18
01/19
15:00
01/19/18
15:00
Options
Bearish flow in Edgewell Personal Care as shares see relative weakness »

Bearish flow in Edgewell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Feb

15:00
01/19/18
01/19
15:00
01/19/18
15:00
General news
Treasury Closing Summary: »

Treasury Closing…

SPY

SPDR S&P 500 ETF Trust

$280.05

0.91 (0.33%)

, SPX

S&P 500

14:53
01/19/18
01/19
14:53
01/19/18
14:53
Periodicals
No deal after Trump, Schumer meeting, Fox News' Pergram says »

Chad Pergram, who covers…

SPY

SPDR S&P 500 ETF Trust

$280.05

0.91 (0.33%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.